PersonFounderScientist
Vivek Lal
Dr. C. Vivek Lal is a physician-scientist turned founder who runs resbiotic, a Birmingham-based wellness company building clinically tested probiotic and prebiotic supplements on a 'Gut-X Axis' platform. A double board-certified neonatologist who directs the Pulmonary Microbiome Lab at the University of Alabama at Birmingham, Lal turned more than 100 peer-reviewed papers and NIH-funded lab work into a string of companies, including the drug-development firm Alveolus Bio and the pediatric chain Urgent Care for Children. In September 2025, resbiotic closed an $8 million Series A, bringing its total funding to $14.5 million.
vivek lalresbioticalveolus biomicrobiomegut-lung axisgut-x axis